A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase 2 clinical trial....
There has been a “shocking” decline in testing for cancer in women across the globe, a new report has revealed. Only 10 per cent of women...
Telephone-delivered acceptance and commitment therapy (ACT) is beneficial for reducing fatigue’s interference with functioning and improves the quality of life for survivors of metastatic breast cancer,...
A clinical trial investigating the treatment TIVDAK for cervical cancer has shown positive results. The topline results from the global Phase 3 innovaTV 301 study demonstrated...
A new, at-home cervical cancer screening test will be launched with the backing of US$10m in funding. The Teal Wand, a at-home screening device and telehealth...
A clinical trial has found that, in patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of...
Researchers have discovered how specific protein regions contribute to breast cancer, potentially paving the way for new treatment. The discovery also offers scientists new tools and...
A new study underscores the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer. A test based on the detection...
A treatment for breast cancer-related vasomotor symptoms (VMS) – known as hot flashes – has seen positive Phase 3 trial results in women with breast cancer or...
Researchers are using AI to enhance detection accuracy and efficiency, paving the way for a transformation in cervical cancer screening. With the aid of deep learning...
